Clearstead Advisors Portfolio holdings
Clearstead Advisors is an independent investment adviser that began in 1989 as Hartland & Co and was renamed Clearstead in 2018. Its main approach is to spread client portfolios across asset classes, regions, company sizes and styles, while some of its rules-based strategies can move money into money market, gold or investment-grade bond funds as a defense. Through its ClearAccess platform, clients can invest in alternative managers one by one, or through a hedge fund series or a private equity series. In 2026 Clearstead took over the clients of The Clarius Group. Flexpoint Ford holds the majority ownership, with the firm's employees holding the rest.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$967M |
| 2 |
NVIDIA
NVDA
|
+$132M |
| 3 |
Baillie Gifford Long Term Global Growth ETF
BGGG
|
+$122M |
| 4 |
Sonoco
SON
|
+$35.5M |
| 5 |
Xtrackers USD High Yield Corporate Bond ETF
HYLB
|
+$23.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PACCAR
PCAR
|
+$287M |
| 2 |
Microsoft
MSFT
|
+$137M |
| 3 |
iShares Core MSCI International Developed Markets ETF
IDEV
|
+$124M |
| 4 |
Dimensional International High Profitability ETF
DIHP
|
+$84.2M |
| 5 |
Starbucks
SBUX
|
+$73.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 61.29% |
| 2 | Technology | 11.98% |
| 3 | Industrials | 7.47% |
| 4 | Financials | 5.38% |
| 5 | Consumer Discretionary | 3.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2076
Bruker
BRKR
$8.48B
| $7.4K | ﹤0.01% |
+123
| New | +$5.74K |
2026 Q2
0 quarters
|
|
2077
Ovid Therapeutics
OVID
$467M
| $7.36K | ﹤0.01% |
2,734
| – | – |
2025 Q4
2 quarters
|
|
2078
Chord Energy
CHRD
$8.06B
| $7.32K | ﹤0.01% |
64
+54
| +540% | +$7.32K |
2024 Q2
8 quarters
|
|
2079
RenaissanceRe
RNR
$14.2B
| $7.29K | ﹤0.01% |
23
+9
| +64% | +$2.7K |
2025 Q2
4 quarters
|
|
2080
Extreme Networks
EXTR
$2.92B
| $7.28K | ﹤0.01% |
+225
| New | +$5.42K |
2026 Q2
0 quarters
|
|
2081
Brink's
BCO
$4.42B
| $7.28K | ﹤0.01% |
77
+62
| +413% | +$6.46K |
2024 Q3
7 quarters
|
|
2082
Haemonetics
HAE
$5.47B
| $7.28K | ﹤0.01% |
97
+50
| +106% | +$3.21K |
2024 Q2
8 quarters
|
|
2083
Sphere Entertainment
SPHR
$3.77B
| $7.27K | ﹤0.01% |
42
+40
| +2,000% | +$5.58K |
2022 Q1
17 quarters
|
|
2084
Invesco Pharmaceuticals ETF
PJP
$575M
| $7.26K | ﹤0.01% |
61
| – | – |
2026 Q1
1 quarter
|
|
2085
Legend Biotech
LEGN
$4.1B
| $7.19K | ﹤0.01% |
+249
| New | +$6.72K |
2026 Q2
0 quarters
|
|
2086
Direxion Auspice Broad Commodity Strategy ETF
COM
$199M
| $7.17K | ﹤0.01% |
220
-236
| -52% | -$7.96K |
2025 Q4
2 quarters
|
|
2087
Planet Fitness
PLNT
$4.19B
| $7.15K | ﹤0.01% |
137
+111
| +427% | +$6.51K |
2025 Q1
5 quarters
|
|
2088
ABM Industries
ABM
$3.17B
| $7.12K | ﹤0.01% |
+161
| New | +$6.6K |
2026 Q2
0 quarters
|
|
2089
Goldman Sachs BDC
GSBD
$1B
| $7.11K | ﹤0.01% |
+750
| New | +$6.97K |
2026 Q2
0 quarters
|
|
2090
Innospec
IOSP
$2.45B
| $7.08K | ﹤0.01% |
+87
| New | +$6.88K |
2026 Q2
0 quarters
|
|
2091
Levi Strauss
LEVI
$8.83B
| $7.05K | ﹤0.01% |
284
-283
| -50% | -$6.38K |
2020 Q3
23 quarters
|
|
2092
Silgan Holdings
SLGN
$4.5B
| $7.05K | ﹤0.01% |
152
+111
| +271% | +$4.44K |
2024 Q2
8 quarters
|
|
2093
JD.com
JD
$35.5B
| $7.05K | ﹤0.01% |
277
+9
| +3% | +$265 |
2025 Q4
2 quarters
|
|
2094
Kennametal
KMT
$2.35B
| $7.05K | ﹤0.01% |
+201
| New | +$7.32K |
2026 Q2
0 quarters
|
|
2095
RLI Corp
RLI
$6.17B
| $7.03K | ﹤0.01% |
119
+99
| +495% | +$5.31K |
2024 Q2
8 quarters
|
|
2096
Reinsurance Group of America
RGA
$17.5B
| $7.02K | ﹤0.01% |
33
-1,000
| -97% | -$209K |
2024 Q2
8 quarters
|
|
2097
Replimune Group
REPL
$1.85B
| $7.01K | ﹤0.01% |
633
+133
| +27% | +$814 |
2025 Q4
2 quarters
|
|
2098
Amplify Junior Silver Miners ETF
SILJ
$2.95B
| $7K | ﹤0.01% |
270
| – | – |
2026 Q1
1 quarter
|
|
2099
Braze
BRZE
$5.19B
| $6.96K | ﹤0.01% |
+321
| New | +$7.15K |
2026 Q2
0 quarters
|
|
2100
American Eagle Outfitters
AEO
$3.31B
| $6.95K | ﹤0.01% |
404
+166
| +70% | +$2.88K |
2025 Q3
3 quarters
|
|
Similar funds
Clearstead Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Clearstead Advisors held 3,754 positions worth $10.6B, down 3.2% from $10.9B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Clearstead Advisors's Q2 2026 filing shows 1,519 new, 1,198 increased, 637 reduced and 93 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 1,450,939 shares worth $997M. The largest sale was PACCAR, an estimated $287M.
By sector, the portfolio is most concentrated in Miscellaneous at 61% of assets, up from 61% a quarter earlier, followed by Technology and Industrials.
- Clearstead Advisors's largest Q2 2026 buy was Vanguard S&P 500 ETF: 1,450,939 shares worth $997M.
- Clearstead Advisors added most to Sonoco in Q2 2026, an estimated $35.5M increase.
- Clearstead Advisors's biggest Q2 2026 reduction was PACCAR, cutting an estimated $287M.
- Clearstead Advisors fully exited iShares Currency Hedged MSCI Japan ETF in Q2 2026, selling an estimated $9.02M.
- Clearstead Advisors's ten largest holdings make up 29% of its $10.6B portfolio in Q2 2026.
- Clearstead Advisors opened 1,519 new positions and closed 93 in Q2 2026.
- Clearstead Advisors's portfolio value fell 3.2% quarter-over-quarter to $10.6B.
Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.